Finn, R. S.
Ahn, D. H.
Javle, M. M.
Tan, B. R. Jr
Weekes, C. D.
Bendell, J. C.
Patnaik, A.
Khan, G. N.
Laheru, D.
Chavira, R.
Christy-Bittel, J.
Barrett, E.
Sawyer, M. B.
Bekaii-Saab, Tanios S.
Funding for this research was provided by:
Array BioPharma, Inc.
Article History
Received: 9 February 2018
Accepted: 3 April 2018
First Online: 22 May 2018
Compliance with ethical standards
:
: Dr. R. S. Finn is a consultant for Bayer, Novartis, Pfizer Inc., Bristol-Myers Squibb. Dr. D. H. Ahn is a consultant for Merrimack. Dr. A. Patnaik receives institutional research funding from Array BioPharma Inc. R. Chavira, J. Christy-Bittel, and Dr. Barrett are current or former employees, and may own stock in, Array BioPharma Inc. All remaining authors have declared no conflicts of interest.